NEW YORK (GenomeWeb News) – Gen-Probe announced after the close of the market Thursday that its second-quarter revenues declined 2 percent year over year, as blood screening revenues dropped sharply.
The San Diego-based molecular diagnostics firm brought in total revenues of $135.9 million for the three-month period ended June 30, compared with revenues of $138.6 million for the second quarter of 2010. Product sales were virtually flat at $132.9 million versus $132.7 million.